L.C. Steggink

research physician

L.C. Steggink
l.c.steggink umcg.nl


  1. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50years

    Jacobse, J. N., Steggink, L., Sonke, G. S., Schaapveld, M., Hummel, Y. M., Steenbruggen, T. G., Lefrandt, J., Nuver, J., Crijns, A., Aleman, B. M. P., Gietema, J. A. & van Leeuwen, F. E., 6-Nov-2019, In : European Journal of Heart Failure. 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O

    Steenbruggen, T. G., Steggink, L., Seynaeve, C. M., van der Hoeven, JJM., Hooning, M. J., Jager, A., Konings, IR., Kroep, J. R., Smit, WM., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, AD., Linn, SC., Schaapveld, M., van Leeuwen, FE., Schroder, C., van Tinteren, H., de Vries, E. G. E., Sonke, G. S. & Gietema, J. A., 2018.

    Research output: Contribution to conferenceAbstractAcademic

View all (10) »

View graph of relations

ID: 503168